Chemicals & Advanced Materials Global On demand · 24-48h

Global Glucoamylase Powder Market Strategic Research Report

Global Glucoamylase Powder Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Glucoamylase Powder Market
$3132025
2.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Type I (Low Debranching) Glucoamylase Powder, Type II (High Debranching) Glucoamylase Powder

By Application: Feed, Food, Brewing, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), Merck KGaA (XTRA: MRK, Darmstadt, Germany), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), Enzyme Development Corporation (Unlisted, New York USA), Creative Enzymes (Unlisted, New York USA), Enzyme Innovation (Unlisted, Chino California USA), Murphy & Son Ltd (Unlisted, Nottingham UK), Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China), Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China), Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China), Sunsonzyme (Unlisted, Beijing China), Henan Yangshao Bio-Engineering Co., Ltd. (Unlisted, Henan China), Longchang Chemical Co., Ltd. (Unlisted, Shandong China)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 127 pages
Market size 2025
$313
Million USD
Forecast CAGR
2.1%
2025-2032
Forecast 2032
$362
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Glucoamylase Powder market size is predicted to grow from US$ 313 million in 2025 to US$ 360 million in 2032; it is expected to grow at a CAGR of 2.1% from 2026 to 2032.

Glucoamylase powder is a solid formulation developed to meet the needs of long-term storage and transportation, dry formulation, and high-temperature processes. It solves the core bottlenecks of liquid enzymes, such as poor stability, high cost, and inconvenient application in tropical storage, long-distance logistics, solid feed premix production, and certain industrial processes requiring direct mixing with dry materials. The upstream supply chain focuses on the breeding of high-yield strains and the supply of solid-state fermentation raw materials such as starch and bran. Downstream, it primarily connects with feed additives requiring solid formulations, some food premixes, brewing and starch sugar factories in remote areas, and export trade. By integrating into customers' solid processing procedures or overcoming harsh storage and transportation conditions, it solves the problems of stability, economy, and convenience in enzyme supply for specific application scenarios, forming a unique supply chain from "strains and agricultural products → solid-state fermentation/drying → solid industrial applications and global distribution." In 2025, the production of glucosylase powder is estimated at approximately 40,000 tons, with an average price of approximately US$8/kg, a gross profit margin of approximately 30%, and a single-line capacity of 500 tons/year.

Global key Glucoamylase Powder players cover Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), Merck KGaA (XTRA: MRK, Darmstadt, Germany), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glucoamylase Powder market?

What factors are driving Glucoamylase Powder market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glucoamylase Powder market opportunities vary by end market size?

How does Glucoamylase Powder break out by Type, by Application?

This report presents a comprehensive overview of the global Glucoamylase Powder market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Type I (Low Debranching) Glucoamylase Powder
  • Type II (High Debranching) Glucoamylase Powder

Segment by Composite Form

  • Single Glucoamylase Powder
  • Composite Saccharification Powder

Segment by Application

  • Feed
  • Food
  • Brewing
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Glucoamylase Powder market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Feed, Food, Brewing evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Glucoamylase Powder Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 2.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$313
2025
Forecast
$362
2032
CAGR
2.1%
2025–2032
Области
5
global
Key companies
Novonesis (CPH: NZYM BBagsværd Denmark)International Flavors & Fragrances Inc. (NYSE: IFFNew York USA)Merck KGaA (XTRA: MRKDarmstadtGermany)Amano Enzyme Inc. (TYO: 2802
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Type I (Low Debranching) Glucoamylase PowderType II (High Debranching) Glucoamylase Powder
By Application
FeedFoodBrewingOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Type I (Low Debranching) Glucoamylase Powder
  • 3.1.3 Type II (High Debranching) Glucoamylase Powder
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Feed
  • 4.1.3 Food
  • 4.1.4 Brewing
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Novonesis (CPH: NZYM B, Bagsværd Denmark)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 International Flavors & Fragrances Inc. (NYSE: IFF, New York USA)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Merck KGaA (XTRA: MRK, Darmstadt, Germany)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Amano Enzyme Inc. (TYO: 2802, Aichi Japan)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Enzyme Development Corporation (Unlisted, New York USA)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Creative Enzymes (Unlisted, New York USA)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Enzyme Innovation (Unlisted, Chino California USA)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Murphy & Son Ltd (Unlisted, Nottingham UK)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Sunsonzyme (Unlisted, Beijing China)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Henan Yangshao Bio-Engineering Co., Ltd. (Unlisted, Henan China)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Longchang Chemical Co., Ltd. (Unlisted, Shandong China)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Glucoamylase Powder market?
The global Glucoamylase Powder market is estimated at US$ 313 million in 2025 (base year) and is projected to reach US$ 360 million by 2032.
How fast is the Glucoamylase Powder market expected to grow?
The market is expected to grow at a CAGR of 2.1% from 2026 to 2032, expanding from US$ 313 million in 2025 to US$ 360 million in 2032, roughly 1.2 times its base-year value.
What does the Glucoamylase Powder market cover?
Glucoamylase powder is a solid formulation developed to meet the needs of long-term storage and transportation, dry formulation, and high-temperature processes. It solves the core bottlenecks of liquid enzymes, such as poor stability, high cost, and inconvenient application in tropical storage, long-distance logistics, solid feed premix production, and certain industrial processes requiring direct mixing with dry materials.
How is the Glucoamylase Powder market segmented by type?
By type, the market is segmented into Type I (Low Debranching) Glucoamylase Powder and Type II (High Debranching) Glucoamylase Powder.
What are the key applications of Glucoamylase Powder?
Key applications covered include Feed, Food, Brewing and Other.
Which companies are profiled in the Glucoamylase Powder market report?
Key players profiled include Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), Merck KGaA (XTRA: MRK, Darmstadt, Germany), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China) and Enzyme Development Corporation (Unlisted, New York USA), among 17 companies covered in total.
What geographies does the Glucoamylase Powder market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Glucoamylase Powder?
What factors are driving Glucoamylase Powder market growth, globally and by region?
What are the main risks and barriers in the Glucoamylase Powder market?
It solves the core bottlenecks of liquid enzymes, such as poor stability, high cost, and inconvenient application in tropical storage, long-distance logistics, solid feed premix production, and certain industrial processes requiring direct mixing with dry materials.
Who should buy the Glucoamylase Powder market report?
The report is intended for manufacturers and solution providers, distributors and end users in Feed, Food and Brewing, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Glucoamylase Powder market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.